Related Experiment Videos
[Symptomatic management in amyotrophic lateral sclerosis (ALS)].
A Czaplinski1, K Schweikert, W Strobel
1Departement of Neurology, Baylor College of Medicine, Houston, Texas, USA. aczaplinski@uhbs.ch
Praxis
|March 10, 2006
Summary
Despite limited disease-specific treatments for amyotrophic lateral sclerosis (ALS), multidisciplinary management significantly enhances patient quality of life and survival. Advances in symptomatic therapies and supportive care offer substantial relief for ALS patients.
Area of Science:
- Neurology
- Clinical Medicine
- Patient Care
Context:
- Amyotrophic lateral sclerosis (ALS) management remains challenging due to the lack of disease-specific treatments.
- Recent years have seen significant progress in symptomatic therapies for ALS patients.
- Multidisciplinary care is crucial for improving outcomes in ALS.
Purpose:
- To review recent advances in symptomatic therapy for amyotrophic lateral sclerosis (ALS).
- To highlight the importance of multidisciplinary management in improving quality of life and survival for ALS patients.
- To discuss supportive and palliative measures available for ALS symptom relief.
Summary:
- Active and aggressive multidisciplinary management improves quality of life and prolongs survival in ALS patients.
- Symptomatic drugs effectively manage conditions like pseudobulbar affect, sialorrhea, and sleep disorders.
- Enteral nutrition and non-invasive ventilation have significantly enhanced the quality of life for individuals with ALS.
Impact:
- Improved quality of life for ALS patients through comprehensive symptom management.
- Extended survival rates due to integrated and aggressive multidisciplinary care approaches.
- Enhanced patient and caregiver communication and decision-making as integral components of ALS management.